Hebei Changshan Biochemical Pharmaceutical Co., Ltd. provided earnings guidance for the first three quarters of 2014. For the period, the company expected net profit attributable to shareholders of CNY 68.6235 million to CNY 78.917 million in the first three quarters of 2014, rising zero to 15% from CNY 68.6235 million a year earlier.